GL1X · GenesisL1 explorer

Research workbench

Crystal structures of JAK1 and JAK2 inhibitor complexes

Analyse Crystal structures of JAK1 and JAK2 inhibitor complexes in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FUP
Type
protein
Length
575 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
MI1
Pockets
6 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28643% helix, 19% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28942% helix, 20% strandO60674

Ligands and binding sites

  • MI1 · 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14950.750.8456MI1
25870.680.7751empty
31630.630.8528MI1
4980.600.8725empty
51380.400.7427empty

Interfaces

1 interface between chains.

  • A–B · 568 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 3FUP · Crystal structures of JAK1 and JAK2 inhibitor complexes · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.